CN109275729B - Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder - Google Patents
Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder Download PDFInfo
- Publication number
- CN109275729B CN109275729B CN201811340961.1A CN201811340961A CN109275729B CN 109275729 B CN109275729 B CN 109275729B CN 201811340961 A CN201811340961 A CN 201811340961A CN 109275729 B CN109275729 B CN 109275729B
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- infant formula
- compound grease
- namely
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 102
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 70
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 70
- 235000020256 human milk Nutrition 0.000 title claims abstract description 69
- 210000004251 human milk Anatomy 0.000 title claims abstract description 69
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 61
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 61
- 239000000194 fatty acid Substances 0.000 title claims abstract description 61
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 61
- 150000001875 compounds Chemical class 0.000 title claims abstract description 49
- 239000004519 grease Substances 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 49
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 36
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 30
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 26
- 235000019197 fats Nutrition 0.000 claims abstract description 24
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 21
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 21
- 239000011707 mineral Substances 0.000 claims abstract description 21
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 18
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 15
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 15
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 14
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 14
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 13
- 241000283707 Capra Species 0.000 claims abstract description 13
- 239000005862 Whey Substances 0.000 claims abstract description 13
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 13
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 13
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 13
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 13
- 235000012680 lutein Nutrition 0.000 claims abstract description 13
- 239000001656 lutein Substances 0.000 claims abstract description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 13
- 229960005375 lutein Drugs 0.000 claims abstract description 13
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 13
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 13
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 13
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 10
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 10
- 229940078499 tricalcium phosphate Drugs 0.000 claims abstract description 10
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims abstract description 10
- 235000019731 tricalcium phosphate Nutrition 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims description 44
- 239000011259 mixed solution Substances 0.000 claims description 42
- 238000004659 sterilization and disinfection Methods 0.000 claims description 32
- 238000000265 homogenisation Methods 0.000 claims description 30
- 239000011812 mixed powder Substances 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 12
- 235000019198 oils Nutrition 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 12
- 239000003549 soybean oil Substances 0.000 claims description 11
- 235000012424 soybean oil Nutrition 0.000 claims description 11
- 235000019482 Palm oil Nutrition 0.000 claims description 10
- 239000002540 palm oil Substances 0.000 claims description 10
- 235000020254 sheep milk Nutrition 0.000 claims description 10
- 239000003240 coconut oil Substances 0.000 claims description 9
- 235000019864 coconut oil Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 235000020238 sunflower seed Nutrition 0.000 claims description 8
- 239000000944 linseed oil Substances 0.000 claims description 7
- 235000021388 linseed oil Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000007580 dry-mixing Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 abstract description 20
- 239000008267 milk Substances 0.000 abstract description 20
- 210000004080 milk Anatomy 0.000 abstract description 20
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 15
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 9
- 229960004488 linolenic acid Drugs 0.000 abstract description 9
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 5
- 238000004945 emulsification Methods 0.000 abstract description 4
- 230000008774 maternal effect Effects 0.000 abstract description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003925 fat Substances 0.000 abstract 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 22
- 235000010755 mineral Nutrition 0.000 description 18
- 239000000203 mixture Substances 0.000 description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 235000021314 Palmitic acid Nutrition 0.000 description 11
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 10
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 9
- 235000021360 Myristic acid Nutrition 0.000 description 9
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 7
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 7
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 7
- 239000005642 Oleic acid Substances 0.000 description 7
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 7
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 7
- 235000021313 oleic acid Nutrition 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 5
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 229910000365 copper sulfate Inorganic materials 0.000 description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 5
- 235000020247 cow milk Nutrition 0.000 description 5
- 229960002104 cyanocobalamin Drugs 0.000 description 5
- 235000000639 cyanocobalamin Nutrition 0.000 description 5
- 239000011666 cyanocobalamin Substances 0.000 description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000011790 ferrous sulphate Substances 0.000 description 5
- 235000003891 ferrous sulphate Nutrition 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- 229960000367 inositol Drugs 0.000 description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 5
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 5
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 229940099596 manganese sulfate Drugs 0.000 description 5
- 239000011702 manganese sulphate Substances 0.000 description 5
- 235000007079 manganese sulphate Nutrition 0.000 description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 5
- 239000001508 potassium citrate Substances 0.000 description 5
- 229960002635 potassium citrate Drugs 0.000 description 5
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 5
- 235000011082 potassium citrates Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 5
- 229960000342 retinol acetate Drugs 0.000 description 5
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 5
- 235000019173 retinyl acetate Nutrition 0.000 description 5
- 239000011770 retinyl acetate Substances 0.000 description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- 239000011781 sodium selenite Substances 0.000 description 5
- 229960001471 sodium selenite Drugs 0.000 description 5
- 235000015921 sodium selenite Nutrition 0.000 description 5
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 5
- 239000011747 thiamine hydrochloride Substances 0.000 description 5
- 229960000344 thiamine hydrochloride Drugs 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 5
- 235000005282 vitamin D3 Nutrition 0.000 description 5
- 239000011647 vitamin D3 Substances 0.000 description 5
- 229940021056 vitamin d3 Drugs 0.000 description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 description 5
- 229960001763 zinc sulfate Drugs 0.000 description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 235000019175 phylloquinone Nutrition 0.000 description 3
- 239000011772 phylloquinone Substances 0.000 description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 3
- 229960001898 phytomenadione Drugs 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 244000266618 Atriplex confertifolia Species 0.000 description 2
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000019046 balanced nutrition Nutrition 0.000 description 2
- 230000037208 balanced nutrition Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000010699 lard oil Substances 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 229940041603 vitamin k 3 Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 108050001786 Alpha-s2 casein Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 240000001359 Origanum dictamnus Species 0.000 description 1
- 235000015987 Origanum dictamnus Nutrition 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 229940050189 cow milk fat Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Dairy Products (AREA)
Abstract
In order to obtain infant formula goat milk powder closer to breast milk and balanced in nutrition structure, the invention records compound grease simulating breast milk fatty acid, infant formula goat milk powder containing the compound grease and a preparation method of the milk powder, and the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following components: 150-490 parts of defatted goat milk powder, 240-520 parts of desalted goat whey powder, 270 parts of compound grease, 1.8-2.2 parts of docosahexaenoic acid, 2.8-3.2 parts of arachidonic acid, 31-33 parts of fructo-oligosaccharide, 2-3.2 parts of vitamin premix, 1.3-1.6 parts of mineral premix, 2.5-3.5 parts of calcium carbonate, 0-1 part of tricalcium phosphate, 0.2-0.5 part of L-carnitine, 0.4-0.5 part of nucleotide and 0.04-0.08 part of lutein. The invention relates to the field of infant formula milk powder, and the formula goat milk powder recorded in the application not only carries out the maternal emulsification and blending on linolenic acid and linoleic acid, but also carries out the maternal emulsification and blending on a plurality of main fats with the most abundant content in breast milk, thereby ensuring the comprehensive nutrition of infants.
Description
Technical Field
The invention relates to the field of infant formula milk powder, in particular to compound grease simulating breast milk fatty acid, infant formula goat milk powder containing the compound grease and a preparation method of the infant formula goat milk powder.
Background
The breast milk is an important and even all nutrient source for infants, and the formula milk powder serving as a substitute and a supplement for the breast milk also needs to meet various nutrient substances required by the growth and development of the infants. With the deepening of dairy science research and the development of dairy production technology, the infant formula milk powder in China has been developed to the fourth generation focusing on the balance of milk powder and nutrition, and the infant formula milk powder is pursued to have refined nutrition proportion and strives to be closer to the components and functions of breast milk, so that the infant fed by the milk powder grows healthier.
The ratio of casein to whey protein of goat milk, cow milk and human milk is about-goat milk (65: 35), cow milk (80: 20) and human milk (60: 40). Compared with cow milk and cow milk powder which are most widely applied at present, the protein composition in goat milk is more similar to that of human milk, and the alpha s 2-casein is very low, is easier to absorb and is not easy to cause allergic reaction of infants, so that the occurrence of infantile diarrhea can be effectively reduced; meanwhile, the total amount of 10 major vitamins contained in each 100 g of goat milk is 780 micrograms. The content of vitamin A, vitamin B1, vitamin B2, vitamin C, pantothenic acid and nicotinic acid can meet the growth requirement of the infant.
In addition, although the fatty acid composition of goat milk is closer to that of human milk than cow milk, the content of medium-short chain fatty acid is up to 20%, and sufficient linoleic acid and arachidonic acid are contained, the fatty acid composition of goat milk is still different from that of human milk fat, and the fatty acid composition still needs to be adjusted by using compound grease. Further research shows that the imbalance of the proportion of the n-3 series polyunsaturated fatty acids and the n-6 series polyunsaturated fatty acids in the infant body is the main reason of causing obesity, low immunity, low intelligence and visual acuity, allergic diseases and other chronic diseases of the infant. In addition, the length of the carbon chain of breast milk fatty acid is an important factor influencing the digestive absorption of infants, and Medium Chain Fatty Acid (MCFA) has important nutrition and immunity effects in the feeding of newborns and infants and is easier to digest and absorb.
The content of MCFA in the mature breast milk is 5.4 percent by calculation, wherein the content of myristic acid (C14: 0) is the highest. Long Chain Fatty Acid (LCFA) content of about 33.7% in mature breast milk, with virtually no significant difference in LCFA content throughout lactation, with palmitic acid (C16: 0) being the most abundant and 22.08% and stearic acid (C18: 0) being the next most abundant and reaching up to 5.38% in mature milk. In addition, according to the results of our tests, it was found that the five highest-content fatty acids in breast milk are oleic acid, linoleic acid, palmitic acid, stearic acid and myristic acid, and their content is 31.17%, 22.57%, 22.08%, 5.38% and 4.58%, respectively, while the five fatty acids in goat milk are 20.79%, 4.43%, 19.08%, 8.45% and 9.03%, which are different from the human milk, and the content of α -linolenic acid in breast milk is much higher than that in goat milk (1.66% in human milk and 0.63% in goat milk).
Most of the formula milk powder on the market at present only adjusts the linoleic acid and the alpha-linolenic acid, and the content of other fatty acids is rarely concerned. In fact, however, the content of other fatty acids is also of great importance for the healthy growth of infants. Oleic acid is the most representative of omega-9 unsaturated fatty acids and is the fatty acid with the most abundant content in breast milk, plays an important role in preventing cardiovascular diseases, apoplexy and other diseases, can promote the development of immune systems of infants, and can cooperate with omega-3 unsaturated fatty acids to improve lipid metabolism of human bodies and reduce the deposition of cholesterol; linoleic acid is essential fatty acid, participates in phospholipid synthesis in human body, is a component of histiocyte, is particularly important for cytoplasmic membrane and mitochondrial structure, has the functions of reducing cholesterol and preventing atherosclerosis, and is a precursor of arachidonic acid; although palmitic acid is one of important fatty acids required by the growth and development of infants, the content of the palmitic acid is rarely concerned when the formula milk powder on the market is prepared at present, and the palmitic acid content is generally higher, so that constipation of the infants is easily caused; the myristic acid is in a significant positive correlation with the cholesterol content in serum, and is one of the important reasons for obesity and cardiovascular and cerebrovascular diseases, and the myristic acid content in the formula milk powder is properly reduced to be close to breast milk when the formula milk powder is prepared, so that the formula milk powder has a positive effect on the cardiovascular and cerebrovascular development of infants.
The inventor shows that good simulation effect is obtained when the proportions of the coconut oil, the palm oil, the sunflower seed oil, the soybean oil and the perilla seed oil in the infant formula are respectively 13.6%, 50%, 14%, 21% and 1.4% in the previous research on blending of fat emulsion in the infant formula (Li Xiaodong, China Dairy industry, 2010, volume 38, stage 20), but no attempt is made to match the effect with the goat milk fat. The results of ginger, wintersweet and the like in the research on novel infant formula milk powder fatty acid mother emulsion (Chinese dairy industry, vol.45, No. 1 of 2017) show that the compound oil containing 6.0% of soybean oil, 7.0% of corn oil and 1.20% of palm oil can also obtain better mother emulsion degree.
For example, CN103053694A discloses an infant milk powder simulating the components of breast milk, in which the structural oil OPO is prepared from palm oil, sunflower oil, rapeseed oil and soybean oil according to a certain ratio, but the technical problem solved by the infant milk powder is that the whole proportion of the infant milk powder is close to that of breast milk and is easier to digest and absorb, and no attention is paid to whether the fatty acids in the final product are close to breast milk or not, and the selection or the source of the fatty acids is focused on the final product. CN105746728A discloses a breast milk simulating infant formula milk powder and a preparation method thereof, wherein the source of fatty acid in the milk powder is also 5 vegetable oils, OPO structure fat is added, but the simulation condition of fat in the milk powder is not concerned, and the milk powder is not provided. CN108157533A discloses a human milk fat analogue and infant formula emulsion and a preparation method thereof, wherein the human milk fat analogue is composed of lard, camellia seed oil, soybean oil and coconut oil, although the human milk fat analogue is close to the human milk fat, the lard is not the best grease source suitable for infants actually.
In view of the reasons, the infant formula milk powder simulating the breast milk fatty acid ratio is made of the sheep milk fat and the vegetable oil, and has great significance.
Disclosure of Invention
One of the purposes of the invention is to provide a compound grease with a component simulating the fatty acid composition of breast milk, which can enable the fatty acid composition of formula goat milk powder to be closer to the breast milk after being added into the formula goat milk powder, so that the six fatty acids of oleic acid, linoleic acid, alpha-linolenic acid, palmitic acid, stearic acid and myristic acid in the formula goat milk powder for infants can simultaneously realize a correlation coefficient with the breast milk of 0.997.
The second purpose of the invention is to provide the infant formula goat milk powder with more similar fatty acid composition to breast milk, balanced nutrition structure and good taste.
The invention also aims to provide a preparation method of the infant formula goat milk powder, which has the advantages of more close fatty acid composition to breast milk, balanced nutritional structure and good taste, is simple to prepare and is suitable for industrial production.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the compound grease simulating breast milk fatty acid is prepared by mixing the following components in percentage by weight: 15-17.5% of sheep milk fat, 3.5-4.5% of linseed oil, 1-1.5% of soybean oil, 30-35% of sunflower seed oil, 25-30% of palm oil and 16-18% of coconut oil.
An infant formula goat milk powder containing compound grease simulating breast milk fatty acid comprises the following components: 150-490 parts of defatted goat milk powder, 240-520 parts of desalted goat whey powder, 270 parts of compound grease, 1.8-2.2 parts of docosahexaenoic acid, 2.8-3.2 parts of arachidonic acid, 31-33 parts of fructo-oligosaccharide, 2-3.2 parts of vitamin premix, 1.3-1.6 parts of mineral premix, 2.5-3.5 parts of calcium carbonate, 0-1 part of tricalcium phosphate, 0.2-0.5 part of L-carnitine, 0.4-0.5 part of nucleotide and 0.04-0.08 part of lutein.
Preferably, the vitamin premix is prepared by mixing the following components in percentage by weight: ascorbic acid 51-57%, dl-alpha-tocopherol acetate 5-7%, nicotinamide 4-5%, D-calcium pantothenate 1-2%, thiamine hydrochloride 1-2.5%, pyridoxine hydrochloride 0.5-1.5%, vitamin A acetate 0.6-1%, folic acid 0.1-0.2%, menadione 0.03-0.07%, biotin 0.005-0.01%, cholecalciferol 0.0008-0.0012%, cyanocobalamin 0.0008-0.0012%, and inositol 28-32%.
Preferably, the mineral premix is prepared by mixing the following components in percentage by weight: 33-36% of calcium carbonate, 17-20% of calcium chloride, 17-20% of sodium citrate, 15-17% of potassium citrate, 7-11% of magnesium chloride, 1-2% of ferrous sulfate, 0.3-0.6% of zinc sulfate, 0.05-0.15% of copper sulfate, 0.02-0.03% of manganese sulfate, 0.001-0.003% of sodium selenite and 0.01-0.03% of potassium iodide.
A preparation method of infant formula goat milk powder containing compound grease simulating breast milk fatty acid comprises the following steps:
the method comprises the following steps: premixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease according to the proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain a mixed solution;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet type sterilizer;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer;
step six: secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to obtain second mixed powder;
step nine: and (3) dry-mixing, namely premixing the raw materials of fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, tricalcium phosphate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid in proportion, and uniformly mixing the premixed raw materials with the second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder.
Preferably, in step one, the temperature of the pre-heating mixing is 45-55 ℃.
Preferably, in the second step and the sixth step, the homogenization temperature is 45-55 ℃ and the homogenization pressure is 15-20 MPa.
Preferably, in the third step, the sterilization temperature is 110-.
Preferably, in the fourth step, the concentration temperature is: 50-60 ℃.
Preferably, in the fifth step, the sterilization temperature is 70-75 ℃, and the sterilization time is 30-90 s.
Compared with the prior art, the invention has the beneficial effects that: on the basis of the previous research, the invention concept of combining the sheep milk fat with the specific vegetable oil is creatively adopted, and the difference between the sheep milk fat and the human milk fat is combined, so that the invention provides the high-quality specific compound oil simulating the fatty acid composition of breast milk, namely 15-17.5% of the sheep milk fat, 3.5-4.5% of linseed oil, 1-1.5% of soybean oil, 30-35% of sunflower seed oil, 25-30% of palm oil and 16-18% of coconut oil, and the components of the compound oil are closely matched to form an organic whole.
The goat milk fat is different from cow milk fat and lard, is rich in medium-short chain fatty acid, so that the composition and the structure of the fatty acid are more beneficial to the digestion and absorption of infants, and on the other hand, the medium-short chain fatty acid also has the functions of resisting cholesterol deposition, preventing intestinal dysfunction and the like, and is easier to play a role together with the goat milk powder. The formula goat milk powder not only carries out the maternal emulsification and blending on linolenic acid and linoleic acid, but also carries out the maternal emulsification and blending on a plurality of fatty acids which are most abundant in breast milk, namely oleic acid, palmitic acid, stearic acid and myristic acid; besides providing sufficient and balanced nutrition for the growth and development period of the infant, the infant formula milk powder can also improve the lipid metabolism function of the infant and reduce the occurrence of obesity and constipation; the content of palmitic acid and myristic acid in the milk powder is properly reduced, the fat deposition in the body of the infant is reduced, the healthy development of the cardiovascular and cerebrovascular systems of the infant is ensured, and the infant is prevented from being obese; compared with formula milk powder only regulating polyunsaturated fatty acid, the regulation of omega-9 unsaturated fatty acid can not only promote the healthy development of the immune system of infants, but also promote linoleic acid and linolenic acid to better exert the physiological functions thereof and promote the digestion and absorption of lipids of infants. After the fat compounded with the goat milk is added into the formula goat milk powder, the fatty acid composition of the formula goat milk powder can be closer to that of the breast milk, and the fat is the infant formula goat milk powder with the correlation coefficient of 0.997 with the breast milk and is formed by six fatty acids of oleic acid, linoleic acid, alpha-linolenic acid, palmitic acid, stearic acid and myristic acid.
Detailed Description
Detailed description of the invention
The compound grease simulating breast milk fatty acid is prepared by mixing the following components in percentage by weight: 15-17.5% of sheep milk fat, 3.5-4.5% of linseed oil, 1-1.5% of soybean oil, 30-35% of sunflower seed oil, 25-30% of palm oil and 16-18% of coconut oil.
An infant formula goat milk powder containing compound grease simulating breast milk fatty acid comprises the following components: 150-490 parts of defatted goat milk powder, 240-520 parts of desalted goat whey powder, 270 parts of compound grease, 1.8-2.2 parts of docosahexaenoic acid, 2.8-3.2 parts of arachidonic acid, 31-33 parts of fructo-oligosaccharide, 2-3.2 parts of vitamin premix, 1.3-1.6 parts of mineral premix, 2.5-3.5 parts of calcium carbonate, 0-1 part of tricalcium phosphate, 0.2-0.5 part of L-carnitine, 0.4-0.5 part of nucleotide and 0.04-0.08 part of lutein.
Preferably, the vitamin premix is prepared by mixing the following components in percentage by weight: ascorbic acid 51-57%, dl-alpha-tocopherol acetate 5-7%, nicotinamide 4-5%, D-calcium pantothenate 1-2%, thiamine hydrochloride 1-2.5%, pyridoxine hydrochloride 0.5-1.5%, vitamin A acetate 0.6-1%, folic acid 0.1-0.2%, menadione 0.03-0.07%, biotin 0.005-0.01%, cholecalciferol 0.0008-0.0012%, cyanocobalamin 0.0008-0.0012%, and inositol 28-32%.
Preferably, the mineral premix is prepared by mixing the following components in percentage by weight: 33-36% of calcium carbonate, 17-20% of calcium chloride, 17-20% of sodium citrate, 15-17% of potassium citrate, 7-11% of magnesium chloride, 1-2% of ferrous sulfate, 0.3-0.6% of zinc sulfate, 0.05-0.15% of copper sulfate, 0.02-0.03% of manganese sulfate, 0.001-0.003% of sodium selenite and 0.01-0.03% of potassium iodide.
A preparation method of infant formula goat milk powder containing compound grease simulating breast milk fatty acid comprises the following steps:
the method comprises the following steps: pre-mixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease with a predetermined proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution, wherein the preheating and mixing temperature is 45-55 ℃;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain the mixed solution, wherein the homogenizing temperature is 45-55 ℃, and the homogenizing pressure is 15-20 Mpa;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet type sterilizer at the temperature of 110-115 ℃ for 4-8 s;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor, wherein the concentration temperature is 50-60 ℃;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer at the sterilization temperature of 70-75 ℃ for 30-90 s;
step six: performing secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization, wherein the homogenization temperature is 45-55 ℃, and the homogenization pressure is 15-20 Mpa;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to obtain second mixed powder;
step nine: and (3) dry-mixing, namely premixing fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, tricalcium phosphate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid raw materials, and uniformly mixing the premixed materials with the second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder.
Example 1
The compound grease simulating breast milk fatty acid is prepared by mixing the following components in percentage by weight: 16.7% of sheep milk fat, 4.1% of linseed oil, 1.2% of soybean oil, 32.8% of sunflower seed oil, 27.9% of palm oil and 17.3% of coconut oil.
An infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following components: the feed comprises, by weight, 180 parts of defatted goat milk powder, 520 parts of desalted goat whey powder, 262 parts of compound grease, 2 parts of docosahexaenoic acid, 3 parts of arachidonic acid, 32 parts of fructo-oligosaccharide, 3.2 parts of vitamin premix, 1.6 parts of mineral premix, 2.5 parts of calcium carbonate, 1 part of tricalcium phosphate, 0.2 part of L-carnitine, 0.42 part of nucleotide and 0.08 part of lutein.
Preferably, the vitamin premix is prepared by mixing the following components in percentage by weight: 54% of ascorbic acid, 6% of dl-alpha-tocopherol acetate, 4.5% of nicotinamide, 1.5% of D-calcium pantothenate, 2% of thiamine hydrochloride, 1% of pyridoxine hydrochloride, 0.8% of vitamin A acetate, 0.14% of folic acid, 0.05% of phytomenadione, 0.008% of biotin, 0.001% of cholecalciferol, 0.001% of cyanocobalamin and 30% of inositol.
Preferably, the mineral premix is prepared by mixing the following components in percentage by weight: 34.9 percent of calcium carbonate, 18.6 percent of calcium chloride, 18.6 percent of sodium citrate, 16.3 percent of potassium citrate, 9.3 percent of magnesium chloride, 1.6 percent of ferrous sulfate, 0.56 percent of zinc sulfate, 0.093 percent of copper sulfate, 0.025 percent of manganese sulfate, 0.002 percent of sodium selenite and 0.02 percent of potassium iodide.
A preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following steps:
the method comprises the following steps: pre-mixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease according to the proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution; wherein the temperature for preheating and mixing is 50 ℃;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain a mixed solution; homogenizing at 50 deg.C under 15 MPa;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet type sterilizer at the sterilization temperature of 115 ℃ for 6 s; if temporary storage is needed, controlling the temperature to be 0-1 ℃ and keeping the temperature for not more than 12 hours;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor; wherein the concentration temperature is controlled at 55 ℃;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer at the sterilization temperature of 70 ℃ for 60 s;
step six: performing secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization, wherein the homogenization temperature is 50 ℃, and the homogenization pressure is 15 Mpa;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to prevent the milk powder from caking, so as to obtain second mixed powder;
step nine: dry-mixing, namely premixing fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, tricalcium phosphate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid in a ratio, and uniformly mixing the premixed material and the second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder; wherein the vitamin premix and the mineral premix are prepared according to the mixture ratio.
Example 2
The compound grease simulating breast milk fatty acid is prepared by mixing the following components in percentage by weight: 16.7% of sheep milk fat, 4.1% of linseed oil, 1.2% of soybean oil, 32.8% of sunflower seed oil, 27.9% of palm oil and 17.3% of coconut oil.
An infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following components: 425 parts of degreased goat milk powder, 325 parts of desalted goat whey powder, 205 parts of compound grease, 2 parts of docosahexaenoic acid, 3 parts of arachidonic acid, 32 parts of fructo-oligosaccharide, 3 parts of vitamin premix, 1.3 parts of mineral premix, 3 parts of calcium carbonate, 0.2 part of L-carnitine, 0.46 part of nucleotide and 0.04 part of lutein.
Preferably, the vitamin premix is prepared by mixing the following components in percentage by weight: 54% of ascorbic acid, 6% of dl-alpha-tocopherol acetate, 4.5% of nicotinamide, 1.5% of D-calcium pantothenate, 2% of thiamine hydrochloride, 1% of pyridoxine hydrochloride, 0.8% of vitamin A acetate, 0.14% of folic acid, 0.05% of phytomenadione, 0.008% of biotin, 0.001% of cholecalciferol, 0.001% of cyanocobalamin and 30% of inositol.
Preferably, the mineral premix is prepared by mixing the following components in percentage by weight: 34.9 percent of calcium carbonate, 18.6 percent of calcium chloride, 18.6 percent of sodium citrate, 16.3 percent of potassium citrate, 9.3 percent of magnesium chloride, 1.6 percent of ferrous sulfate, 0.56 percent of zinc sulfate, 0.093 percent of copper sulfate, 0.025 percent of manganese sulfate, 0.002 percent of sodium selenite and 0.02 percent of potassium iodide.
A preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following steps:
the method comprises the following steps: pre-mixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease according to the proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution; wherein the temperature for preheating and mixing is 53 ℃;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain a mixed solution; homogenizing at 53 deg.C and 18 Mpa;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet sterilizer at the sterilization temperature of 113 ℃ for 5 s; if temporary storage is needed, controlling the temperature to be 0-1 ℃ and keeping the temperature for not more than 12 hours;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor; wherein the concentration temperature is controlled at 58 ℃;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer at the sterilization temperature of 73 ℃ for 50 s;
step six: performing secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization, wherein the homogenization temperature is 53 ℃, and the homogenization pressure is 18 Mpa;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to prevent the milk powder from caking, so as to obtain second mixed powder;
step nine: dry-mixing, namely premixing the raw materials of fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid in proportion, and uniformly mixing the premixed raw materials with second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder; wherein the vitamin premix and the mineral premix are prepared according to the mixture ratio.
Example 3
The compound grease simulating breast milk fatty acid is prepared by mixing the following components in percentage by weight: 16.7% of sheep milk fat, 4.1% of linseed oil, 1.2% of soybean oil, 32.8% of sunflower seed oil, 27.9% of palm oil and 17.3% of coconut oil.
An infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following components: 485 parts of defatted goat milk powder, 240 parts of desalted goat whey powder, 230 parts of compound grease, 2 parts of docosahexaenoic acid, 3 parts of arachidonic acid, 32 parts of fructo-oligosaccharide, 3 parts of vitamin premix, 1.3 parts of mineral premix, 3 parts of calcium carbonate, 0.2 part of L-carnitine, 0.46 part of nucleotide and 0.04 part of lutein.
Preferably, the vitamin premix is prepared by mixing the following components in percentage by weight: 54% of ascorbic acid, 6% of dl-alpha-tocopherol acetate, 4.5% of nicotinamide, 1.5% of D-calcium pantothenate, 2% of thiamine hydrochloride, 1% of pyridoxine hydrochloride, 0.8% of vitamin A acetate, 0.14% of folic acid, 0.05% of phytomenadione, 0.008% of biotin, 0.001% of cholecalciferol, 0.001% of cyanocobalamin and 30% of inositol.
Preferably, the mineral premix is prepared by mixing the following components in percentage by weight: 34.9 percent of calcium carbonate, 18.6 percent of calcium chloride, 18.6 percent of sodium citrate, 16.3 percent of potassium citrate, 9.3 percent of magnesium chloride, 1.6 percent of ferrous sulfate, 0.56 percent of zinc sulfate, 0.093 percent of copper sulfate, 0.025 percent of manganese sulfate, 0.002 percent of sodium selenite and 0.02 percent of potassium iodide.
A preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid comprises the following steps:
the method comprises the following steps: pre-mixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease according to the proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution; wherein the temperature for preheating and mixing is 45 ℃;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain a mixed solution; homogenizing at 45 deg.C under 20 MPa;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet type sterilizer at the sterilization temperature of 110 ℃ for 4 s; if temporary storage is needed, controlling the temperature to be 0-1 ℃ and keeping the temperature for not more than 12 hours;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor; wherein the concentration temperature is controlled at 60 ℃;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer at the sterilization temperature of 75 ℃ for 90 s;
step six: performing secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization, wherein the homogenization temperature is 55 ℃, and the homogenization pressure is 20 Mpa;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to prevent the milk powder from caking, so as to obtain second mixed powder;
step nine: dry-mixing, namely premixing fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, tricalcium phosphate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid in a ratio, and uniformly mixing the premixed material and the second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder; wherein the vitamin premix and the mineral premix are prepared according to the mixture ratio.
Infant formula is mostly divided into 3 stages. The scientific proportioning of the formula is carried out according to the body requirements of the babies at different ages so as to adapt to the requirements of the growth and development of the babies.
One stage at 0-6 months, called infant formula.
The product is a second-stage product in 6-12 months, and is called infant formula.
The product is three-stage in 12-36 months, and is called infant formula.
The goat milk powder prepared in the embodiment 1 of the invention is mainly suitable for infants, and the goat milk powder prepared in the embodiments 2 and 3 is suitable for older infants and children.
Comparative experiments were performed by gas chromatography-mass spectrometry (GC-MS), and the results are shown in table 1, wherein the lard oil was replaced by the same amount of lard oil as the mutton fat in example 1, and other conditions were unchanged.
Table 1 relative content of fatty acids (% total fatty acids)
Note: (1) a, b are different from each other in significance
Correlation analysis is performed by SPSS software, and it can be found that the correlation coefficient of fatty acid distribution in breast milk in example 1 is 0.989; the correlation coefficient of the six fatty acids of oleic acid, linoleic acid, alpha-linolenic acid, palmitic acid, stearic acid and myristic acid reaches 0.997.
TABLE 2 EXAMPLE 1 correlation coefficient with human milk fatty acid Pearson
Total fatty acids | Six kinds of selected fatty acids |
0.989 | 0.997 |
The results show that the composition and ratio of fatty acids of example 1 more closely resemble those of breast milk. The use of lard instead of sheep fat can reduce the content of short-chain fatty acids in the product, increase the content of cholesterol, and have poor effect, and in the research process, the ideal effect can not be achieved no matter how the dosage of the lard and other vegetable oils is adjusted, and sheep fat forms a harmonious organic whole with other vegetable oils and other components in the formula milk powder.
The product of the invention is the infant formula goat milk powder which simultaneously realizes the correlation coefficient with breast milk to be 0.997 by using six fatty acids of oleic acid, linoleic acid, alpha-linolenic acid, palmitic acid, stearic acid and myristic acid.
The above description is only a preferred embodiment of the present invention, and all equivalent changes and modifications made in accordance with the claims of the present invention should be covered by the present invention.
Claims (6)
1. A preparation method of infant formula goat milk powder containing compound grease simulating breast milk fatty acid is characterized by comprising the following steps:
the infant formula goat milk powder comprises the following components: 150-490 parts of defatted goat milk powder, 240-520 parts of desalted goat whey powder, 270 parts of compound grease simulating breast milk fatty acid, 1.8-2.2 parts of docosahexaenoic acid, 2.8-3.2 parts of arachidonic acid, 31-33 parts of fructo-oligosaccharide, 2-3.2 parts of vitamin premix, 1.3-1.6 parts of mineral premix, 2.5-3.5 parts of calcium carbonate, 0-1 part of tricalcium phosphate, 0.2-0.5 part of L-carnitine, 0.4-0.5 part of nucleotide and 0.04-0.08 part of lutein;
the compound grease is prepared by mixing the following components in percentage by weight: 15-17.5% of sheep milk fat, 3.5-4.5% of linseed oil, 1-1.5% of soybean oil, 30-35% of sunflower seed oil, 25-30% of palm oil and 16-18% of coconut oil;
the method comprises the following steps:
the method comprises the following steps: premixing, namely preheating and mixing the degreased goat milk powder, the desalted goat whey powder and the compound grease according to the proportion, adding water for dissolving, and uniformly mixing to obtain a mixed solution;
step two: homogenizing, namely homogenizing the mixed solution prepared in the step one in a homogenizer to obtain a mixed solution;
step three: sterilizing, namely sterilizing the mixed solution homogenized in the step two in a sheet type sterilizer;
step four: concentrating, namely concentrating the sterilized mixed liquor obtained in the step three in an evaporator to obtain concentrated mixed liquor;
step five: performing secondary sterilization, namely performing secondary sterilization on the concentrated mixed solution obtained in the step four in a tubular sterilizer;
step six: secondary homogenization, namely performing secondary homogenization on the concentrated mixed solution subjected to secondary sterilization;
step seven: drying, namely feeding the concentrated mixed solution after the secondary homogenization into a spray drying tower for spray drying to obtain first mixed powder;
step eight: performing secondary drying, namely performing secondary drying on the spray-dried first mixed powder by using a fluidized bed to obtain second mixed powder;
step nine: and (3) dry-mixing, namely premixing the raw materials of fructo-oligosaccharide, vitamin premix, mineral premix, calcium carbonate, tricalcium phosphate, L-carnitine, nucleotide, lutein, docosahexaenoic acid and arachidonic acid in proportion, and uniformly mixing the premixed raw materials with the second mixed powder in a dry mixer to obtain third mixed powder, namely the infant formula goat milk powder.
2. The preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid according to claim 1, which is characterized in that: in the first step, the temperature of the preheating and mixing is 45-55 ℃.
3. The preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid according to claim 1, which is characterized in that: in the second step and the sixth step, the homogenization temperature is 45-55 ℃, and the homogenization pressure is 15-20 Mpa.
4. The preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid according to claim 1, which is characterized in that: in the third step, the sterilization temperature is 110-115 ℃, and the sterilization time is 4-8 s.
5. The preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid according to claim 1, which is characterized in that: in step four, the concentration temperature is: 50-60 ℃.
6. The preparation method of the infant formula goat milk powder containing the compound grease simulating breast milk fatty acid according to claim 1, which is characterized in that: in the fifth step, the sterilization temperature is 70-75 ℃, and the sterilization time is 30-90 s.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811340961.1A CN109275729B (en) | 2018-11-12 | 2018-11-12 | Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811340961.1A CN109275729B (en) | 2018-11-12 | 2018-11-12 | Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109275729A CN109275729A (en) | 2019-01-29 |
CN109275729B true CN109275729B (en) | 2021-11-09 |
Family
ID=65175430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811340961.1A Active CN109275729B (en) | 2018-11-12 | 2018-11-12 | Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109275729B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110742130A (en) * | 2019-11-14 | 2020-02-04 | 东北农业大学 | Infant formula goat milk powder added with liposome simulating breast milk fat structure and preparation method thereof |
CN113115841A (en) * | 2019-12-30 | 2021-07-16 | 丰益(上海)生物技术研发中心有限公司 | Phospholipid-containing infant formula |
CN111838327B (en) * | 2020-07-23 | 2022-09-06 | 海普诺凯营养品有限公司 | Grease for milk powder base powder and preparation method thereof |
CN111758774A (en) * | 2020-08-07 | 2020-10-13 | 西安百跃羊乳集团有限公司 | Perilla frutescens formula goat milk powder and preparation method thereof |
CN112931628B (en) * | 2021-03-26 | 2022-02-15 | 东北农业大学 | Liposome simulating breast milk lipid structure, formula powder for premature infant and preparation method |
CN114208895A (en) * | 2021-12-24 | 2022-03-22 | 光明乳业股份有限公司 | Novel infant formula milk powder with optimized fat composition and preparation method thereof |
CN116076578A (en) * | 2023-03-22 | 2023-05-09 | 北大荒完达山乳业股份有限公司 | Infant formula milk powder containing alpine ecological cow milk compound fat and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876107A (en) * | 1985-07-12 | 1989-10-24 | Unilever Patent Holdings Bv | Substitute milk fat compositions |
CN102283288A (en) * | 2011-07-04 | 2011-12-21 | 澳优乳业(中国)有限公司 | Infant formula goat milk powder added with structural grease and preparation method thereof |
CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
CN103053694A (en) * | 2013-02-18 | 2013-04-24 | 杨凌圣妃乳业有限公司 | Infant goat milk powder simulating components of breast milk and preparation method thereof |
CN104561145A (en) * | 2013-10-17 | 2015-04-29 | 常州骏石生物技术有限公司 | Preparation method of 1, 3-dioleoyl-2-palmitoyl triglyceride |
CN104996576A (en) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | Goat milk powder for infant and preparation method thereof |
CN107251949A (en) * | 2017-08-03 | 2017-10-17 | 江西美庐乳业集团有限公司 | A kind of preparation method for the full-cream sheep milk powder of without smelling of mutton for retaining goat milk aliphatic acid |
CN108142558A (en) * | 2017-12-22 | 2018-06-12 | 贝因美婴童食品股份有限公司 | A kind of infant formula goat milk powder and preparation method thereof |
CN108522655A (en) * | 2018-04-13 | 2018-09-14 | 内蒙古欧世蒙牛乳制品有限责任公司 | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula |
-
2018
- 2018-11-12 CN CN201811340961.1A patent/CN109275729B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876107A (en) * | 1985-07-12 | 1989-10-24 | Unilever Patent Holdings Bv | Substitute milk fat compositions |
CN102283288A (en) * | 2011-07-04 | 2011-12-21 | 澳优乳业(中国)有限公司 | Infant formula goat milk powder added with structural grease and preparation method thereof |
CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业(中国)有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
CN103053694A (en) * | 2013-02-18 | 2013-04-24 | 杨凌圣妃乳业有限公司 | Infant goat milk powder simulating components of breast milk and preparation method thereof |
CN104561145A (en) * | 2013-10-17 | 2015-04-29 | 常州骏石生物技术有限公司 | Preparation method of 1, 3-dioleoyl-2-palmitoyl triglyceride |
CN104996576A (en) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | Goat milk powder for infant and preparation method thereof |
CN107251949A (en) * | 2017-08-03 | 2017-10-17 | 江西美庐乳业集团有限公司 | A kind of preparation method for the full-cream sheep milk powder of without smelling of mutton for retaining goat milk aliphatic acid |
CN108142558A (en) * | 2017-12-22 | 2018-06-12 | 贝因美婴童食品股份有限公司 | A kind of infant formula goat milk powder and preparation method thereof |
CN108522655A (en) * | 2018-04-13 | 2018-09-14 | 内蒙古欧世蒙牛乳制品有限责任公司 | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula |
Non-Patent Citations (1)
Title |
---|
婴儿配方奶粉中的油脂配料;袁向华等;《中国乳品工业》;20090131(第01期);第50-53和57页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109275729A (en) | 2019-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109275729B (en) | Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder | |
CN102283288B (en) | Infant formula goat milk powder added with structural grease and preparation method thereof | |
CN103549034B (en) | Nutritional compound oil with anti-oxidation function | |
CN104996576A (en) | Goat milk powder for infant and preparation method thereof | |
CN110742130A (en) | Infant formula goat milk powder added with liposome simulating breast milk fat structure and preparation method thereof | |
WO2016176988A1 (en) | Preparation method combining enzymatic acid hydrolysis and physical mixing for breast milk fat substitute | |
CN105120688A (en) | Infant formula with a low content of MCFAs in specific proportions and a relatively high content of unsaturated fatty acids, and its use in promoting the healthy establishment of cognitive function in infants | |
CN105076484A (en) | Infant formula milk powder for improving intestinal absorption and preparation method thereof | |
US20240081360A1 (en) | Base oil for oils and fats used in functional food, preparation method and use thereof | |
US20240108050A1 (en) | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid | |
US20040191294A1 (en) | Health composition | |
CN110584084A (en) | Emulsion stabilizer and nutrient emulsion containing same | |
CN110637888A (en) | Preterm/low birth weight infant formula powder and preparation method thereof | |
CN106819472A (en) | One boar biological feedstuff and preparation method thereof, purposes | |
CN105120687A (en) | Infant formula with a low content of medium-chain fatty acids in specific proportions, and its use in promoting and/or ensuring a balanced growth in infants | |
CN111838327B (en) | Grease for milk powder base powder and preparation method thereof | |
CN110604180A (en) | Formula and preparation process of novel infant milk powder | |
CN112219902A (en) | Oil composition suitable for foods for infants of low-age | |
CN107173464A (en) | A kind of edible oil suitable for infant | |
CN106721064A (en) | A kind of herd boar promotees the breeding ester composition of aliphatic acid three | |
CN113994923B (en) | Breeding boar propagation promoting prevention and control method | |
AU2015367307B2 (en) | Infant nutrition with hydrolysed protein and palmitic acid | |
US20210037854A1 (en) | Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive | |
CN106819561A (en) | A kind of laying hen biological feedstuff and preparation method thereof, purposes | |
CN115500393B (en) | Fatty acid ester composition containing OPLa triglyceride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |